389 related articles for article (PubMed ID: 17321600)
1. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis.
Rodríguez-Cortés A; Fernández-Bellón H; Ramis A; Ferrer L; Alberola J; Solano-Gallego L
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):190-8. PubMed ID: 17321600
[TBL] [Abstract][Full Text] [Related]
2. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
Reis AB; Teixeira-Carvalho A; Vale AM; Marques MJ; Giunchetti RC; Mayrink W; Guerra LL; Andrade RA; Corrêa-Oliveira R; Martins-Filho OA
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):102-16. PubMed ID: 16621021
[TBL] [Abstract][Full Text] [Related]
3. A long term experimental study of canine visceral leishmaniasis.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Int J Parasitol; 2007 May; 37(6):683-93. PubMed ID: 17239885
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs.
Fernández-Bellon H; Solano-Gallego L; Rodríguez A; Rutten VP; Hoek A; Ramis A; Alberola J; Ferrer L
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):163-9. PubMed ID: 15922459
[TBL] [Abstract][Full Text] [Related]
5. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs.
Cardoso L; Schallig HD; Cordeiro-da-Silva A; Cabral M; Alunda JM; Rodrigues M
Vet Immunol Immunopathol; 2007 May; 117(1-2):35-41. PubMed ID: 17321602
[TBL] [Abstract][Full Text] [Related]
6. Anti-Leishmania IgA in urine samples from dogs with clinical leishmaniasis.
Todolí F; Solano-Gallego L; Ojeda A; Quintana J; Lloret A; Roura X; Alberola J; Rodríguez-Cortés A
Vet Parasitol; 2009 Jan; 159(1):17-23. PubMed ID: 19019547
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
8. Associations among immunological, parasitological and clinical parameters in canine visceral leishmaniasis: Emaciation, spleen parasitism, specific antibodies and leishmanin skin test reaction.
Dos-Santos WL; Jesus EE; Paranhos-Silva M; Pereira AM; Santos JC; Baleeiro CO; Nascimento EG; Moreira ED; Oliveira GG; Pontes-de-Carvalho LC
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):251-9. PubMed ID: 18359091
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of natural Leishmania infection in asymptomatic dogs in the absence of specific humoral immunity.
Cabral M; McNerney R; Gomes S; O'Grady J; Frame I; Sousa JC; Miles MA; Alexander J
Arch Inst Pasteur Tunis; 1993; 70(3-4):473-9. PubMed ID: 7802503
[TBL] [Abstract][Full Text] [Related]
11. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
12. Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.
Gómez-Ochoa P; Castillo JA; Gascón M; Zarate JJ; Alvarez F; Couto CG
Vet J; 2009 Feb; 179(2):259-63. PubMed ID: 18023375
[TBL] [Abstract][Full Text] [Related]
13. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
Reis AB; Martins-Filho OA; Teixeira-Carvalho A; Giunchetti RC; Carneiro CM; Mayrink W; Tafuri WL; Corrêa-Oliveira R
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):87-95. PubMed ID: 19054576
[TBL] [Abstract][Full Text] [Related]
14. Immune response to Leishmania infantum in healthy horses in Spain.
Fernández-Bellon H; Solano-Gallego L; Bardagí M; Alberola J; Ramis A; Ferrer L
Vet Parasitol; 2006 Jan; 135(2):181-5. PubMed ID: 16213661
[TBL] [Abstract][Full Text] [Related]
15. Splenic immune responses during canine visceral leishmaniasis.
Strauss-Ayali D; Baneth G; Jaffe CL
Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
[TBL] [Abstract][Full Text] [Related]
16. Profile of anti-Leishmania antibodies related to clinical picture in canine visceral leishmaniasis.
de Freitas JC; Lopes-Neto BE; de Abreu CR; Coura-Vital W; Braga SL; Reis AB; Nunes-Pinheiro DC
Res Vet Sci; 2012 Oct; 93(2):705-9. PubMed ID: 22226072
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G and E responses in various stages of canine leishmaniosis.
Iniesta L; Gállego M; Portús M
Vet Immunol Immunopathol; 2005 Jan; 103(1-2):77-81. PubMed ID: 15626463
[TBL] [Abstract][Full Text] [Related]
18. Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis.
Teixeira Neto RG; Giunchetti RC; Carneiro CM; Vitor RW; Coura-Vital W; Quaresma PF; Ker HG; de Melo LA; Gontijo CM; Reis AB
Vet Parasitol; 2010 May; 169(3-4):248-57. PubMed ID: 20188477
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
[TBL] [Abstract][Full Text] [Related]
20. Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs.
Bourdoiseau G; Hugnet C; Gonçalves RB; Vézilier F; Petit-Didier E; Papierok G; Lemesre JL
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):71-8. PubMed ID: 19046774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
